title: A 5-day: the favourable way?
authors.affiliation: Department of Haematology, Beaumont Hospital, Beaumont Road, Dublin, 9, Ireland, maeveannoreilly@yahoo.co.uk.
authors.forename: Maeve A
authors.initials: MA
authors.lastname: O'Reilly
authors.forename: Cathy
authors.initials: C
authors.lastname: McHale
authors.forename: Ahmed
authors.initials: A
authors.lastname: Almazmi
authors.forename: Abdul
authors.initials: A
authors.lastname: Hameed
authors.forename: Dalia
authors.initials: D
authors.lastname: Benjamin
authors.forename: Niamh
authors.initials: N
authors.lastname: O'Connell
authors.forename: Philip
authors.initials: P
authors.lastname: Murphy
authors.forename: John
authors.initials: J
authors.lastname: Quinn
authors.forename: Patrick
authors.initials: P
authors.lastname: Thornton
authors.forename: Peter
authors.initials: P
authors.lastname: O'Gorman
authors.forename: Hana
authors.initials: H
authors.lastname: Frankova
authors.forename: Jeremy
authors.initials: J
authors.lastname: Sargent
authors.forename: Estelle
authors.initials: E
authors.lastname: Verburgh
authors.forename: John
authors.initials: J
authors.lastname: McHugh
authors.forename: Pamela
authors.initials: P
authors.lastname: Evans
authors.forename: Helen
authors.initials: H
authors.lastname: Enright
mesh_terms: D001374:Azacitidine / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D009190:Myelodysplastic Syndromes / Q000188:drug therapy* / Q000401:mortality*
chemical_list: D001374:Azacitidine